Bovie Medical Corporation Announces Completion of Development of Monopolar and Bipolar Modular Forceps; Expected to Significantly Impact Future Growth

MELVILLE, N.Y.--(BUSINESS WIRE)--Bovie Medical Corporation (the “Company”) (Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced that its Canadian subsidiary has completed the prototypes of the Company’s Polaris™ line of monopolar and bipolar modular forceps. The patent pending Polaris™ line offers all the benefits of the Company’s recently FDA cleared Modular Ergonomic Grip (MEG) forceps line while expanding the cartridge offerings to bipolar endoscopic cartridges (jaws and electrodes), between 4-12 mm in diameter.

MORE ON THIS TOPIC